Limerick-based medical technology firm rebrands after sale
Teleflex Medical based in Annacotty becomes Ingenyx
MEDICAL devices manufacturer Teleflex, which employs hundreds of people in Annacotty, has rebranded to become Ingenyx.
Approximately 700 staff are employed in Limerick at the company, which has been renamed after parts of Teleflex – including locally here – were sold to private equity firms Montagu and Kohlberg.
The transaction was first revealed last December, with the new company launching earlier this month.
In an ironic twist, Teleflex was in the past headquartered in another Limerick – a township in Pennsylvania, USA. In fact, it was located on South Limerick Road.
Staff in Limerick develop and manufacturer parts for medical equipment, such as tiny tubes, wires, catheters, stitches and special fibres.
Companies around the world use its products to make medical devices.
Greg Stotts, formerly chief executive of Teleflex Medical continues in that role at Ingenyx, and Matt Jennings, senior operating partner at Kohlberg, will serve as executive chairman of the board. “Medical device companies face growing pressure to innovate faster while managing complexity, risk, and cost,” Mr Jennings said. “Ingenyx is uniquely positioned to meet that need by serving as a collaborative extension of our customers’ teams, combining design for manufacturability methodology, and our proprietary intelligence databank with a deep understanding of the decisions that shape successful products.”
Under the Ingenyx brand, the company will expand its focus beyond traditional contract manufacturing development to help customers navigate increasingly complex product development, material selection, scalability, and lifecycle challenges.
“Ingenyx reflects both who we are and where we’re headed,” Mr Stotts added. “For decades, we’ve helped medical device companies bring innovative products to market. As an independent company, we have an opportunity to invest further in the capabilities, expertise, and technologies that help our customers make smarter decisions and accelerate their path to commercialisation.”